Neuphoria Therapeutics Inc 6-K, filed Jul 5, 2022
Neuphoria Therapeutics Inc. (NEUP)
About this 6-K
Neuphoria Therapeutics Inc filed this 6-K on July 5, 2022.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of July, 2022
(Commission File No. 001-41157)
BIONOMICS LIMITED
(Translation of registrant’s name into English)
200 Greenhill Road
Eastwood SA 5063
Tel: +618 8150 7400
(Address of registrant’s principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1):
Yes ☐ No ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7):
Yes ☐ No ☐
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On July 04, 2022, the Company lodged a Notification of Cessation of Securities in relation to the expiry of unlisted options under an employee incentive plan on Appendix 3H with the ASX, as required by the laws and regulations of Australia, to disclose a change in interests in securities and contracts of the Company. The Notification of Cessation of Securities is furnished herewith as Exhibit 99.1 to this report on Form 6-K.
1
EXHIBIT INDEX
|
|
Exhibit
|
Description
|
99.1 |
|
|
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
|
|
|
|
Bionomics Limited |
|
|
(Registrant) |
|
|
|
|
|
By: |
/s/ Errol De Souza
|
|
Name: |
Errol De Souza, Ph.D. |
|
Title: |
Executive Chairman |
Date: July 05, 2022
1
|
Notification of cessation of +securities |
Announcement Summary
Entity name
BIONOMICS LIMITED
Announcement Type
New announcement
Date of this announcement
Monday July 04, 2022
Details of +securities that have ceased
Number of
ASX +security +securities that The +securities have Date of
code Security description have ceased ceased due to cessation
BNOAO OPTION EXPIRING 386,600 Expiry of option or other 12/06/2022
VARIOUS DATES EX convertible security without
VARIOUS PRICES exercise or conversion
Refer to next page for full details of the announcement
Exhibit 99.1
|
Notification of cessation of +securities |
Part 1 - Announcement Details
1.1 Name of +Entity
BIONOMICS LIMITED
We (the entity named above) provide the following information about our issued capital.
1.2 Registered Number Type ABN
1.3 ASX issuer code BNO
1.4 The announcement is
New announcement
Registration Number
53075582740
1.5 Date of this announcement 4/7/2022
Notification of cessation of +securities 2 / 4
Exhibit 99.1
|
Notification of cessation of +securities |
Part 2 - Details of +equity securities or +debt securities that have ceased
ASX +Security Code and Description
BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Unquoted +equity securities that have ceased
Number of securities that have ceased
386,600
Reason for cessation
Expiry of option or other convertible security without exercise or conversion
Date of cessation
12/6/2022
Is the entity paying any consideration for the cessation?
No
Any other information the entity wishes to notify to ASX about the cessation?
Notification of cessation of +securities 3 / 4
Exhibit 99.1
|
Notification of cessation of +securities |
Part 3 - Issued capital following changes
Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:
3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)
Total number of ASX +security code and description +securities on issue
BNO : ORDINARY FULLY PAID 1,353,350,744
3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
Total number of ASX +security code and description +securities on issue
BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 79,056,617
BNOAS : WARRANTS 142,000,000
Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.
Notification of cessation of +securities 4 / 4